PI
Proteomics International Laboratories Ltd.
PIQ.AX · ASX
$0.16 +0.00% (+$0.00)
1M -9.09%
Market Cap $25.6M
P/E Ratio -
Div. Yield -
ROE 96.48%
Piotroski F-Score Weak
1/9Valuation
23 /100
Expensive P/B 4.41x
P/S 92.20x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 11.51%
Rev. growth 27.53%
FCF growth N/A
Profitability
0 /100
Weak Net margin 3,078.86%
Op. margin 4,275.74%
FCF margin 2,835.17%
Quality
0 /100
Poor ROE 96.48%
ROA 96.36%
Asset turnover 0.03x
Debt
69 /100
Low Current ratio 3.19x
Int. coverage -288.41x
Debt/Equity 0.06x
Stability
43 /100
Moderate Rev. volatility 50.15%
EPS volatility 6.81%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PIQ.AX
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
David N. Morris
Employees
161
Headquarters
Nedlands
Prihajajoči dogodki
25 FEB.
Earnings
Upcoming earnings report